J. George et al., INFLUENCE OF CLINICOPATHOLOGICAL VARIABLES ON CYP PROTEIN EXPRESSION IN HUMAN LIVER, Journal of gastroenterology and hepatology, 11(1), 1996, pp. 33-39
Drug metabolism is usually impaired in malnourished patients with deco
mpensated cirrhosis, but the separate influence of clinicopathological
variables, including nutritional status, on the expression of hepatic
cytochrome P450 proteins has nor been well characterized. We determin
ed the hepatic content of CYP1A2, CYP2C8/10, CYP2E1 and CYP3A proteins
in 71 subjects, 21 with histologically normal livers and 50 with chro
nic liver disease, and then tested for potential relationships between
patient variables and individual CYP proteins by multivariate linear
regression analysis. Variables analysed included nutritional status (d
etermined by experienced clinicians), serum albumin and bilirubin conc
entrations, prothrombin time, the grade of ascites and hepatic encepha
lopathy, and the Child-Pugh score. Impaired nutrition and cachexia wer
e associated with reductions of CYP2C8/10 levels of approximately 19 a
nd 39%, respectively, relative to cases in which nutrition was replete
. Similarly, CYP2E1 protein was reduced by approximately 13 and 26%, a
ccording to the apparent severity of nutritional impairment. In contra
st, nutritional status did not contribute to variability in expression
of CYP1A2 or CYP3A proteins. Of the clinicopathological variables ana
lysed, only serum bilirubin was shown to have an independent influence
on CYP protein content. Thus, elevated serum bilirubin concentrations
were associated with significant declines in the contents of CYP1A2 a
nd CYP2C8/10 but not CYP3A or CYP2E1. The mechanisms for the effects o
f nutritional status and serum bilirubin concentration on the levels o
f CYP proteins are unclear, but could be mediated by factors such as c
ytokines, dietary composition and alterations in the level of serum bi
le acids. Knowledge of the influence of clinicopathological factors an
d nutritional status on CYP expression should lead to more rational dr
ug prescribing in patients with hepatic disease.